RainBio, a pioneer in ocular gene therapy, focuses on corneal blindness.
RainBIO has raised $250K in total funding. The most recent round was Debt Financing. The last funding was announced in July 2021.
RainBIO's investors include North Carolina Biotechnology Center.
RainBIO is headquartered in Raleigh, United States.
RainBio, a pioneer in ocular gene therapy, focuses on corneal blindness.
RainBIO is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RainBIO — Funding & Investors." VCBacked, July 30, 2021, https://www.vcbacked.co/company/rainbio. Accessed August 14, 2026.
VCBacked. (2021). RainBIO — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rainbio
{{cite web |title=RainBIO — Funding & Investors |url=https://www.vcbacked.co/company/rainbio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated